{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:24:43Z","timestamp":1791066283059,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.euroneuro.2007.01.005","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T15:22:19Z","timestamp":1176909739000},"page":"573-579","source":"Crossref","is-referenced-by-count":192,"title":["Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder"],"prefix":"10.1016","volume":"17","author":[{"given":"Lena","family":"Brundin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Peters\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lil","family":"Tr\u00e4skman-Bendz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2007.01.005_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.npep.2004.06.004","article-title":"Stereological analysis of the hypothalamic hypocretin\/orexin neurons in an animal model of depression","volume":"38","author":"Allard","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.1978.tb02357.x","article-title":"CPRS\u2014the comprehensive psychopathological rating scale","volume":"271","author":"Asberg","year":"1978","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000079749","article-title":"Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness","volume":"52","author":"Baumann","year":"2004","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1212\/01.wnl.0000167605.02541.f2","article-title":"Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury","volume":"65","author":"Baumann","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib6","series-title":"Suicide prevention in the seventies","first-page":"7","article-title":"Classification and nomenclature","author":"Beck","year":"1973"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1027\/0227-5910.25.4.147","article-title":"Psychiatric diagnoses and suicide: revisiting the evidence","volume":"25","author":"Bertolote","year":"2004","journal-title":"Crisis"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib8","article-title":"Orexin and psychiatric symptoms in suicide attempters","author":"Brundin","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/01.WNL.0000078194.53210.48","article-title":"Low levels of ventricular CSF orexin\/hypocretin in advanced PD","volume":"61","author":"Drouot","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00001756-200002280-00038","article-title":"Sleep in the Wistar\u2013Kyoto rat, a putative genetic animal model for depression","volume":"11","author":"Dugovic","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1210\/jc.74.6.1325","article-title":"Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans","volume":"74","author":"Geracioti","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/sleep\/29.3.295","article-title":"Diurnal variation in CSF orexin-A in healthy male subjects","volume":"29","author":"Grady","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000127023","article-title":"Altered hypothalamic\u2013pituitary\u2013adrenocortical regulation in healthy subjects at high familial risk for affective disorders","volume":"62","author":"Holsboer","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib15","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1210\/jc.2002-020638","article-title":"Dynamics of the pituitary\u2013adrenal ensemble in hypocretin-deficient narcoleptic humans: blunted basal adrenocorticotropin release and evidence for normal time-keeping by the master pacemaker","volume":"11","author":"Kok","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1471-4159.2006.03693.x","article-title":"Delta sleep-inducing peptide (DSIP): a still unresolved riddle","volume":"97","author":"Kovalzon","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jnen\/64.3.224","article-title":"Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder","volume":"64","author":"Manaye","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(02)00032-X","article-title":"CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture","volume":"110","author":"Nishino","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib22","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.regpep.2003.12.014","article-title":"Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons","volume":"118","author":"Sakamoto","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib25","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","author":"Saper","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000115711","article-title":"Characterization, properties and multivariate functions of delta-sleep-inducing peptide (DSIP)","volume":"23","author":"Schoenenberger","year":"1984","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10401230109148954","article-title":"Sleep and suicide in psychiatric patients","volume":"13","author":"Singareddy","year":"2001","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/pr.58.1.4","article-title":"Orexins in the regulation of the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"58","author":"Spinazzi","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib29","article-title":"Neurochemical regulation of sleep","author":"Steiger","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","article-title":"The stress system in the human brain in depression and neurodegeneration","volume":"4","author":"Swaab","year":"2005","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00001756-200103050-00008","article-title":"Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats","volume":"12","author":"Taheri","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archpsyc.1981.01780310031002","article-title":"Monoamine metabolites in CSF and suicidal behavior","volume":"38","author":"Traskman","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0924-977X(92)90018-4","article-title":"HPA-related CSF neuropeptides in suicide attempters","volume":"2","author":"Traskman-Bendz","year":"1992","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/sleep\/26.4.427","article-title":"Sleep disturbances and hypocretin deficiency in Niemann\u2013Pick disease type C","volume":"26","author":"Vankova","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.euroneuro.2007.01.005_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jad.2003.07.002","article-title":"Low CSF leptin in female suicide attempters with major depression","volume":"81","author":"Westling","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0753-3322(00)89047-2","article-title":"Stress system alterations and mood disorders in suicidal patients","volume":"54","author":"Westrin","year":"2000","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.euroneuro.2007.01.005_bib37","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1523\/JNEUROSCI.3459-04.2004","article-title":"Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response","volume":"24","author":"Winsky-Sommerer","year":"2004","journal-title":"J. Neurosci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X07000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X07000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T07:20:29Z","timestamp":1556349629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X07000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0924977X07000181"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2007.01.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}